Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 04, 2024
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance.
Journal: Hepatology communications
Published: June 08, 2023
Improved mortality prediction for pediatric acute liver failure using dynamic prediction strategy.
Journal: Journal of pediatric gastroenterology and nutrition
Published: May 14, 2023
Assessing predictive discrimination performance of biomarkers in the presence of treatment-induced dependent censoring.
Journal: Journal of the Royal Statistical Society. Series C, Applied statistics
Published: December 05, 2022
Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children.
Journal: Hepatology communications
Published: November 10, 2022
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.
Journal: Hepatology communications
Published: June 16, 2022
Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020: "Acute Liver Failure in Children": Treatment and Directions for Future Research.
Journal: Journal of pediatric gastroenterology and nutrition
Published: February 28, 2022
Proceedings of ESPGHAN Monothematic Conference 2020: "Acute Liver Failure in Children": Diagnosis and Initial Management.
Journal: Journal of pediatric gastroenterology and nutrition
Published: February 28, 2022
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease.
Journal: Hepatology (Baltimore, Md.)
Published: February 10, 2022
Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.
Journal: Hepatology communications
Published: January 20, 2022
Use of funded multicenter prospective longitudinal databases to inform clinical trials in rare diseases-Examination of cholestatic liver disease in Alagille syndrome.
Journal: Hepatology communications
Published: December 23, 2021
Last Updated: 09/26/2026